Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Filament Health Corp N.FH

Alternate Symbol(s):  FLHLF

Filament Health Corp. is a Canada-based clinical-stage natural psychedelic drug development company. The Company’s platform of intellectual property enables the discovery, development, and delivery of natural psychedelic medicines. The Company’s first three botanical drug candidates are standardized, purified extracts of Psilocybe cubensis fruiting bodies include: PEX010 Psilocybin - oral... see more

Recent & Breaking News (NEO:FH)

Filament Health announces second quarter 2021 financial results

Stockhouse Editorial August 16, 2021

Filament Health Announces Q2 2021 Financial Results

PR Newswire August 16, 2021

The StockTalk Cannabis Report: Aug 6, 2021

Dave Jackson August 6, 2021

Filament Health is the First Public Company to be Issued a Patent for Extraction of Natural Psilocybin

PR Newswire August 5, 2021

This is the FIRST Public Psychedelics Company to Notch a Patent for Extracting Natural Psilocybin

Jocelyn Aspa August 5, 2021

Regulatory Approvals Place Filament Health at the Forefront of Natural Psychedelic Research and Manufacturing

PR Newswire July 29, 2021

The StockTalk Cannabis Report: July 23, 2021

Dave Jackson July 23, 2021

Filament Health to Host Virtual Investor Event

PR Newswire July 19, 2021

Exclusively-Natural Psychedelic Pharma Company, Filament Health, Lists on the NEO Exchange

Business Wire June 24, 2021

Filament Health Corp. Announces Approval for Listing on the NEO Exchange

Canada NewsWire June 22, 2021